Mercor, which connects AI labs with domain experts for training their foundational AI models, has raised $350 million at a $10 billion valuation, the company confirmed to TechCrunch. Felicis Ventures, which led the company’s previous $100 million Series B at a $2 billion valuation, is also leading this round. Existing investors Benchmark and General Catalyst, […]
Mercor quintuples valuation to $10B with $350M Series C Read More »
Mercor, a startup that connects companies like OpenAI and Meta with domain experts needed to train and refine their foundational AI models, is in discussions with investors for a Series C round, according to a marketing document viewed by TechCrunch and two sources familiar with the deal talks. Felicis, a returning investor, is considering doubling
Sources: AI training startup Mercor eyes $10B+ valuation on $450 million run rate Read More »
Mercor, a startup that connects companies like OpenAI and Meta with domain experts needed to train and refine their foundational AI models, is in discussions with investors for a Series C round, according to two sources familiar with the deal talks and a marketing document viewed by TechCrunch. The company is currently targeting a valuation
Sources: AI training startup Mercor eyes $10B+ valuation on $450M run rate Read More »
While highly sought after, federal software contracts frequently come with a hidden cost: Achieving government SaaS security compliance, known as FedRAMP, can take years and require substantial resources. Achieving this certification typically takes up to three years and costs more than $3 million, covering everything from security operations engineer salaries to security audits, according to
Knox lands $6.5M to compete with Palantir in the federal compliance market Read More »
Medical and administrative staff are increasingly overwhelmed with piles of paperwork they have to fill out every day. Dozens, if not hundreds, of startups, are seeing opportunities to make those bureaucratic processes less burdensome with the help of generative AI. These companies are building AI medical scribes, platforms for pre-authorizing health insurance payments, and products
Ashwin Nandakumar and Ashwin Jainarayanan were working on their doctorates at adjacent departments in Oxford, but they didn’t know each other. Nandakumar, who was studying oncology, one day stumbled across a curious dataset for prostate cancer, with which he needed sequencing help. “I reached out to a few friends asking to help me analyze this
Granza Bio grabs $7M seed from Felicis and YC to advance delivery of cancer treatments Read More »
